COLUMBUS - A shift in federal marijuana policy could give Ohio’s cannabis industry a financial edge—and potentially draw more customers across the border from Michigan. The U.S. Department of Justice has moved state-licensed medical marijuana from Schedule I to Schedule III, easing federal restrictions for part of the industry. It’s not full legalization. But for operators,
WASHINGTON DC - A major federal shift in marijuana policy is underway—but for Michigan’s booming cannabis industry, the impact is more nuanced than headlines suggest. The Trump administration announced Thursday it is moving to reclassify marijuana from a Schedule I drug to Schedule III under the Drug Enforcement Administration framework—formally recognizing medical value for the
WASHINGTON DC - Michigan’s multibillion-dollar cannabis industry—already under pressure from falling prices and tight margins—may have just been thrown a lifeline from Washington. The Trump administration is expected to move marijuana from Schedule I to Schedule III under the federal Controlled Substances Act, a long-awaited shift that could fundamentally change how cannabis businesses operate, bank,
WASHINGTON DC - The U.S. Drug Enforcement Administration has clarified the definition of THC in the context of industrial hemp, potentially placing greater restrictions on intoxicating products derived from hemp compounds, according to a letter issued by the agency. The 2018 Farm Bill defined hemp as cannabis with less than 0.3% delta-9 THC. The DEA’s
WASHINGTON DC - Officials with the Drug Enforcement Administration are reportedly resisting calls to reschedule marijuana, creating tension with the White House as President Joe Biden continues to tout his role in directing the cannabis review. That’s according to an article published by The Wall Street Journal on Saturday, with the report citing “people familiar
WASHINGTON DC - A former Food and Drug Administration official says he’d be "shocked" if the DEA does not reschedule cannabis by next year's presidential election, and that he expects the DEA will ultimately accept the recent Health and Human Services’ recommendation to ease restrictions on cannabis by reclassifying it as a Schedule III drug under the Controlled Substances
